Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127227471 | 12722747 | 1 | I | 20160902 | 20160907 | 20160907 | PER | US-GILEAD-2016-0232006 | GILEAD | 0.00 | A | M | Y | 0.00000 | 20160907 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127227471 | 12722747 | 1 | PS | STRIBILD | COBICISTATELVITEGRAVIREMTRICITABINETENOFOVIR DISOPROXIL FUMARATE | 1 | Unknown | UNK | 203100 | TABLET | |||||||||
127227471 | 12722747 | 2 | SS | PREZISTA | DARUNAVIR ETHANOLATE | 1 | Unknown | UNK | 0 | ||||||||||
127227471 | 12722747 | 3 | SS | PLAQUENIL /00072602/ | HYDROXYCHLOROQUINE DIPHOSPHATE | 1 | Unknown | 400 MG, BID | U | 0 | 400 | MG | BID |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127227471 | 12722747 | 1 | HIV infection |
127227471 | 12722747 | 2 | HIV infection |
127227471 | 12722747 | 3 | Product used for unknown indication |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127227471 | 12722747 | Drug interaction | |
127227471 | 12722747 | T-lymphocyte count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127227471 | 12722747 | 1 | 2013 | 0 | ||
127227471 | 12722747 | 2 | 2013 | 0 |